학술논문
Vosoritide therapy in children with achondroplasia aged 3−59 months: a multinational, randomised, double-blind, placebo-controlled, phase 2 trial
Document Type
Article
Author
Source
In: The Lancet Child and Adolescent Health . (The Lancet Child and Adolescent Health, January 2024, 8(1):40-50)
Subject
Language
English
ISSN
23524642